Controversies In The Treatment Of Lung Cancer

Under the auspices of the 12th International Symposium on Special Aspects in Radiotherapy 2008 in Berlin, acknowledged experts presented their perspectives on small and non-small cell lung cancer, reflecting the latest standards and engaging in controversies in the diagnosis and treatment of this disease.In the first part of this volume, aspects of the diagnostic workup are highlighted from the histopathologist's point of view, followed by presentations concerning the value of PET-CT and whole-body MRI in the staging of lung cancer. The use and current methods in bronchoscopy, endoscopic ultrasound, video-endoscopy and mediastinoscopy are discussed in detail. The second section presents surgical and radio-oncological treatment concepts for stage I/II non-small cell lung cancer including stereotactic radiotherapy. The third section outlines the curative options for stage III NSCLC: extended surgical approaches , definitive radiochemotherapy and current concepts in adjuvant therapies. Emphasis is also placed on altered fractionation schemes in radiotherapy. Section 4 is dedicated to palliative procedures and the last section gives an in-depth presentation of small cell lung cancer.This book provides an excellent overview of up-to-date standards and future strategies in lung cancer treatment. It will be of great value to surgeons, radiation oncologists, pulmonary specialists and other clinicians interested in this disease.

This special edition of Frontiers in Oncology reviews the current efficacy and limitations of surgical and radiotherapeutic management of lung cancer and provides insight into how local management options may change in the future.

Presenting contrasting viewpoints of leading national and international authorities, this illuminating reference explores unresolved issues in the treatment of patients with lung cancer. Providing evidence-based approaches to specific concerns in therapeutic management, Controversies in Lung Cancer guides clinicians confronting decisions regarding day-to-day oncologic practice. Includes opposing opinions on, among other issues, the timing of thoracic radiotherapy for patients with limited stage small cell lung cancer, by Dr. Nevin Murray, British Columbia Cancer Agency, Vancouver, Canada, and Dr. Michael Perry, Ellis Fischel Cancer Center, Columbia, Missouri! Emphasizing quality of life, nutrition, and supportive care of lung cancer patients, Controversies in Lung Cancer considers dose intensification of chemotherapy in small cell and non-small cell lung cancer the value of three-dimensional conformal radiotherapy endobronchial brachytherapy management of superior sulcus tumors and more! With over 1700 literature references, drawings, photographs, and tables, Controversies in Lung Cancer is a timely resource for medical, radiation, and thoracic oncologists; thoracic surgeons; pulmonologists; hematologists; primary care physicians; nurses; and medical school students and residents in these disciplines.

Presenting contrasting viewpoints of leading national and international authorities, this illuminating reference explores unresolved issues in the treatment of patients with lung cancer. Providing evidence-based approaches to specific concerns in therapeutic management, Controversies in Lung Cancer guides clinicians confronting decisions regarding day-to-day oncologic practice. Includes opposing opinions on, among other issues, the timing of thoracic radiotherapy for patients with limited stage small cell lung cancer, by Dr. Nevin Murray, British Columbia Cancer Agency, Vancouver, Canada, and Dr. Michael Perry, Ellis Fischel Cancer Center, Columbia, Missouri! Emphasizing quality of life, nutrition, and supportive care of lung cancer patients, Controversies in Lung Cancer considers dose intensification of chemotherapy in small cell and non-small cell lung cancer the value of three-dimensional conformal radiotherapy endobronchial brachytherapy management of superior sulcus tumors and more! With over 1700 literature references, drawings, photographs, and tables, Controversies in Lung Cancer is a timely resource for medical, radiation, and thoracic oncologists; thoracic surgeons; pulmonologists; hematologists; primary care physicians; nurses; and medical school students and residents in these disciplines.

This issue of Thoracic Surgery Clinics of North America, guest edited by Dr. Michael Lanuti, is devoted to Current Controversies in Thoracic Surgery. Dr. Lanuti has assembled expert authors to review the following topics: Management of Stage IIIA Non-Small Cell Lung Cancer; Management of Oligometastatic Non-Small Cell Lung Cancer; Current Treatment of Mesothelioma (Extrapleural Pneumonectomy or Pleurectomy); Stents as Primary Therapy for Esophageal Perforation; Lymph Node Dissection and Pulmonary Metastectomy; Mediastinal Staging: Endobronchial Ultrasound or Mediastinoscopy; Induction Therapy for Esophageal Cancer; Appropriate Surgical Treatment of Stage I Non-Small Cell Lung Cancer; Stereotactic Body Radiotherapy for Stage I Non-Small Cell Lung Cancer; Benefit of Plication for Paralyzed Diaphragm; Video-assisted Thoracoscopic Surgery (VATS) Sympathectomy for Hyperhidrosis; Induction Therapy for Thymoma, and more!

This special edition of Frontiers in Oncology reviews the current efficacy and limitations of surgical and radiotherapeutic management of lung cancer and provides insight into how local management options may change in the future.